Novosyn® Quick in Patients Undergoing Episiotomy Closure
Conditions:
Episiotomy Wound
Sponsor: Aesculap AG
trial.available_in:
БГ
Overview
Retrospective, monocentric clinical study on the clinical performance of Novosyn® Quick in patients undergoing episiotomy closure.
Description
The study design is a retrospective, consecutive series of women with a spontaneous vaginal delivery who required an indicated episiotomy with Novosyn® Quick between the period January 2020 - December 2020 at Hospital General de Catalunya.
All women treated with Novosyn® Quick between January 2020 - December 2020 at the Hospital General de Catalunya will be analyzed. The investigator team will access medical records for the cohort of patients identified.
Who can participate
Inclusion Criteria:
* Women who underwent an indicated episiotomy between January 2020 - December 2020 at the Hospital General de Catalunya (Sant Cugat del Vallès, Spain) and received Novosyn® Quick
Exclusion Criteria:
* No exclusion criteria have been set
БГ